Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 71 for cerebrovascular

Edit search filters
  1. A Study to Evaluate Anticoagulation for Stroke Prevention and Recovery After Intracerebral Hemorrhage (ICH)

    Jacksonville, FL

  2. A Study of Atrial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

    Jacksonville, FL

  3. A Study Comparing Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients with Non-valve Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention

    Scottsdale/Phoenix, AZ

  4. A Study of Continuous Positive Airway Pressure Treatment for Obstructive Sleep Apnea to Prevent Cardiovascular Disease

    Rochester, MN

  5. SCD Use to Prevent DVT in Patients with PICC Lines

    Rochester, MN

  6. Sleep for Stroke Management and Recovery Trial

    Jacksonville, FL

  7. Stroke Mitigation in A-fib Reasoning Tool for Shared Decision Making

    Rochester, MN

  8. A Study to Evaluate Clazosentan on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain Caused By Bleeding On the Surface

    Jacksonville, FL

  9. Plasma Endocannabinoid Levels in Patients with Ischemic Cerebrovascular Disease

    Rochester, MN

  10. IPSS Consortium Study

    Rochester, MN

.

Mayo Clinic Footer